CVI Investments, Inc. - 11 Nov 2025 SCHEDULE 13G Report for Salarius Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (SLRX)

Filing Manager: CVI Investments, Inc.
Reporting Manager: CVI Investments, Inc.
Security: Salarius Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol: SLRX
Shares outstanding: 3,661,606 shares
Disclosed Ownership: 362,499 shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 18 Nov 2025, 11:53:37 UTC
Date of event: 11 Nov 2025
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
CVI Investments, Inc.	9.9%	362,499	0	362,499	/s/ Sarah Travis	Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc.	9.9%	362,499	0	362,499	/s/ Sarah Travis	Sarah Travis, Assistant General Counsel and Assistant Secretary